Korea Bio-Gen Co.Ltd (318000) — Capital Reinvestment Ratio
Korea Bio-Gen Co.Ltd (318000) has a Capital Reinvestment Ratio of 0.07x as of September 2025, meaning it reinvests 0% of its operating cash flow (₩1.85 Billion) in capital expenditures (₩129.79 Million). See 318000 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Korea Bio-Gen Co.Ltd Capital Reinvestment Ratio (2017–2024)
This chart tracks Korea Bio-Gen Co.Ltd's Capital Reinvestment Ratio across 8 annual periods. Check 318000 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Korea Bio-Gen Co.Ltd (2017–2024)
Year-by-year Capital Reinvestment Ratio for Korea Bio-Gen Co.Ltd from 2017 to 2024. For live market cap and broader valuation context, see 318000 market cap overview.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.19x | ₩4.29 Billion | ₩5.12 Billion | ▲ +366.1% |
| 2023 | 0.26x | ₩9.47 Billion | ₩2.42 Billion | ▼ -81.3% |
| 2022 | 1.37x | ₩1.67 Billion | ₩2.29 Billion | ▲ +79.6% |
| 2021 | 0.76x | ₩3.09 Billion | ₩2.36 Billion | ▲ +125.5% |
| 2020 | 0.34x | ₩2.58 Billion | ₩872.46 Million | ▼ -59.4% |
| 2019 | 0.83x | ₩3.05 Billion | ₩2.55 Billion | ▲ +96.7% |
| 2018 | 0.42x | ₩1.98 Billion | ₩840.93 Million | ▼ -24.6% |
| 2017 | 0.56x | ₩1.38 Billion | ₩777.66 Million | — |